| |
| |
|
| Insider
Information: |
Hamelin Paul |
| Relationship: |
President |
| City: |
East Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
124,765 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
124,765 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
President |
2011-02-14 |
124,765 |
2006-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2011-02-14 |
4 |
AS |
$9.89 |
$53,117 |
D/D |
(5,371) |
124,765 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2010-09-16 |
4 |
D |
$20.27 |
$703,349 |
D/D |
(34,699) |
130,136 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2010-09-16 |
4 |
A |
$20.27 |
$1,548,506 |
D/D |
76,394 |
164,835 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2010-02-16 |
4 |
AS |
$13.80 |
$95,547 |
D/D |
(6,925) |
82,949 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-12-17 |
4 |
AS |
$5.77 |
$10,252 |
D/D |
(1,777) |
97,034 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-12-13 |
4 |
A |
$5.94 |
$297,000 |
D/D |
50,000 |
98,811 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-12-09 |
4 |
AS |
$13.36 |
$26,476 |
D/D |
(1,981) |
89,874 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-09-11 |
4 |
AS |
$15.00 |
$60,000 |
D/D |
(4,000) |
91,855 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-05-26 |
4 |
AS |
$5.76 |
$6,791 |
D/D |
(1,179) |
95,855 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-02-17 |
4/A |
AS |
$5.77 |
$10,252 |
D/D |
(1,777) |
97,034 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-02-13 |
4/A |
A |
$5.94 |
$297,000 |
D/D |
50,000 |
98,811 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2008-12-09 |
4 |
AS |
$4.71 |
$11,853 |
D/D |
(2,515) |
48,811 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2008-12-08 |
4 |
A |
$4.53 |
$28,688 |
D/D |
6,333 |
51,326 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Commerical Operations |
• – – |
2008-11-04 |
4 |
A |
$5.17 |
$49,115 |
D/D |
9,500 |
47,919 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Commerical Operations |
• – – |
2008-11-04 |
4 |
D |
$5.17 |
$15,127 |
D/D |
(2,926) |
44,993 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-24 |
4 |
AS |
$25.25 |
$31,083 |
D/D |
(1,231) |
38,419 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-24 |
4 |
OE |
$5.11 |
$6,290 |
D/D |
1,231 |
39,650 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-23 |
4 |
OE |
$12.11 |
$60,550 |
D/D |
5,000 |
44,651 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-23 |
4/A |
OE |
$5.11 |
$25,550 |
D/D |
5,000 |
43,419 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-23 |
4/A |
AS |
$25.75 |
$128,751 |
D/D |
(5,000) |
38,419 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-23 |
4 |
S |
$25.75 |
$128,751 |
D/D |
(5,000) |
39,651 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-19 |
4/A |
AS |
$24.89 |
$47,994 |
D/D |
(1,928) |
38,419 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-19 |
4/A |
OE |
$12.11 |
$23,348 |
D/D |
1,928 |
40,347 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-19 |
4 |
S |
$24.89 |
$47,994 |
D/D |
(1,928) |
39,651 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-19 |
4 |
OE |
$12.11 |
$23,348 |
D/D |
1,928 |
41,579 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
